Ion Pharmaceuticals, Sheffield Medical Technologies Inc. autoimmune/inflammation news

SHM created Ion Pharmaceuticals, a Boston-based subsidiary to develop SHM's anti-proliferative program to treat diseases caused by abnormal ion transport and cell proliferation. Ion will manage physi...